Assessing Specialty Pharmaceutical Trends Reshaping the Field for the Future
May 11th 2022Doug Long, vice president, Industry Relations, IQVIA, discusses notable trends reshaping specialty pharmaceutical channels and the impact of these developments on the role of the pharmacist in the health care team.
Watch
Clinical Overview: PT027 for Exacerbation Risk Reduction, Improved Lung Function in Asthma
May 11th 2022The combination of albuterol/budesonide shows promise in lowering the risk of severe exacerbations and improved lung function compared to albuterol as a rescue inhaler in patients with asthma.
Read More
Fourth-Year Pharmacy Students Help Patients and Practitioners in Transitional Care
Students are being exposed to new patient experiences through collaboration with practitioners.
Read More
FDA Approves Baricitinib for Certain Adult Patients Hospitalized With COVID-19
May 11th 2022Baricitinib (Olumiant) approved for the treatment of adult patients hospitalized with COVID-19 who require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation.
Read More
Overview of Blockbuster Drugs in Oncology Approved in 2022, in the Pipeline for Approval in 2023
May 10th 2022Ray Tancredi, divisional vice president of Specialty Pharmacy, Development & Brand Rx/Vaccine Purchasing at Walgreens, discusses blockbuster drugs in the oncology space that have been approved this year or may be hitting the market soon.
Watch